Bovine growth hormone transgenic mice display alterations in locomotor activity and brain monoamine neurochemistry

Endocrinology

Volumn 140, Issue 12, 1999, Pages 5619-5625

  Söderpalm, Bo ^a   Ericson, Mia ^a   Bohlooly y, Mohammad ^a   Engel, Jörgen A ^a   Törnell, Jan ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; 5 HYDROXYINDOLEACETIC ACID; BRAIN MONOAMINE; DEXAMPHETAMINE; DOPAMINE; GROWTH HORMONE; SEROTONIN;

5 HYDROXYINDOLEACETIC ACID BRAIN LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOPAMINE BRAIN LEVEL; HABITUATION; HYPERACTIVITY; LOCOMOTION; MALE; MOUSE; NEUROCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; SEROTONIN BRAIN LEVEL; TRANSGENIC MOUSE;

EID: 0033305474     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.140.12.7181     Document Type: Article

References (48)

1. Quality of life of adults with growth hormone deficiency: A controlled study
2. Quality of life assessment before and after growth hormone treatment in adults with growth hormone deficiency
3. Quality of life in adults with growth hormone (GH) deficiency: Response to treatment with recombinant human GH in a placebo-controlled 21 month trial
4. Cognitive impairments and mood disturbances in growth hormone deficient men
5. Impaired social status of growth hormone deficient adults as compared to controls with short or normal stature
6. Decreased psychological well-being in adult patients with growth hormone deficiency
7. Treatment of adults with growth hormone (GH) deficiency with recombinant human GH
8. Effects of growth hormone substitution on mental performance in adults with growth hormone deficiency: A pilot study
9. Growth hormone replacement therapy in adult hypopituitary patients with growth hormone deficiency: Combined data from 12 European placebo-controlled clinical trials
10. Growth hormone: Neurocrine and neuroendocrine perspectives
11. Treatment of growth hormone-deficient adults with recombinant human growth hormone increases the concentration of growth hormone in the cerebrospinal fluid and affects neurotransmitters
12. In situ hybridization to rat brain pituitary gland of growth hormone cDNA
13. Growth hormone-(GH) immunoreactivity in rodent and primate CNS: Distribution, characterization and presence posthypophysectomy
14. Localization and ontogeny of growth hormone receptor gene expression in the central nervous system
15. Somatogenic and lactogenic binding sites in rat brain and liver: Quantitative autoradiographic localization
16. Characterization of putative growth hormone receptors in human choroid plexus
17. Age-related reduction of human growth hormone-binding sites in the human brain
18. Role of the mesolimbic system in the mechanism of action of antidepressants
19. Biogenic amine hypothesis of affective disorders
20. Brain dopamine and reward
21. Drugs of abuse: Anatomy, pharmacology and function of reward pathways
22. Serotonergic and dopaminergic involvement in ethanol intake
23. Ethanol and nicotine consumption and preference in transgenic mice overexpressing the bovine growth hormone gene
24. A psychomotor stimulant theory of addiction
25. Neurochemical aspects of the euphoria induced by dependence-producing drugs
26. Disproportional bone growth and reduced weight gain in gonadectomized male bovine growth hormone transgenic and normal mice
27. Evidence for a role for dopamine in the diazepam locomotor stimulating effect
28. Catecholamines and behavior
29. The neural basis of drug craving: An incentive-sensitization theory of addiction
30. The pharmacology and neural circuitry of sensitization to psychostimulants
31. Molecular mechanisms of drug addiction
32. Neuroendocrine and reproductive consequences of overexpression of growth hormone in transgenic mice
33. Induction but not expression of behavioural sensitization to nicotine is dependent on glucocorticoids
34. 3H-dihydromorphine from rat brain opioid receptors
35. Growth hormone treatment affects brain neurotransmitters and thyroxine
36. Receptor mediated control of dopamine metabolism
37. The serotonin hypothesis of depression
38. Effects of growth hormone on brain biogenic amine levels
39. The effects of corticosterone on 5-HT receptor funktion in rodents
40. Effects of glucocorticoids on 5-HT1A presynaptic function in the mouse
41. Electrophysiologically-identified serotonin receptors in the rat CNS. Effect of antidepressant treatment
42. 1 Agonists reduce 5-hydroxytryptamine release in rat hippocamous in vivo as determined by brain microdialysis
43. 1(A) agonist 8-OH-DPAT preferentially activates cell body autoreceptors in rat brain in vivo
44. Effects of the 5-HT receptor agonist, 8-OH-DPAT, on ethanol preference in the rat
45. Involvement of the serotonergic system in ethanol intake in the rat
46. 1(A) Receptor agonists reduce ethanol-induced locomotor activity in mice
47. Effects of adrenalectomy and glucocorticoids on rat brain dopamine receptors